115 related articles for article (PubMed ID: 31147087)
21. Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Satoi S; Yamaue H; Kato K; Takahashi S; Hirono S; Takeda S; Eguchi H; Sho M; Wada K; Shinchi H; Kwon AH; Hirano S; Kinoshita T; Nakao A; Nagano H; Nakajima Y; Sano K; Miyazaki M; Takada T
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):590-600. PubMed ID: 23660962
[TBL] [Abstract][Full Text] [Related]
22. Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer.
Sandini M; Patino M; Ferrone CR; Alvarez-Pérez CA; Honselmann KC; Paiella S; Catania M; Riva L; Tedesco G; Casolino R; Auriemma A; Salandini MC; Carrara G; Cristel G; Damascelli A; Ippolito D; D'Onofrio M; Lillemoe KD; Bassi C; Braga M; Gianotti L; Sahani D; Fernández-Del Castillo C
JAMA Surg; 2018 Sep; 153(9):809-815. PubMed ID: 29801062
[TBL] [Abstract][Full Text] [Related]
23. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
Kwon D; McFarland K; Velanovich V; Martin RC
Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
[TBL] [Abstract][Full Text] [Related]
24. Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study.
Klompmaker S; van Hilst J; Gerritsen SL; Adham M; Teresa Albiol Quer M; Bassi C; Berrevoet F; Boggi U; Busch OR; Cesaretti M; Dalla Valle R; Darnis B; De Pastena M; Del Chiaro M; Grützmann R; Diener MK; Dumitrascu T; Friess H; Ivanecz A; Karayiannakis A; Fusai GK; Labori KJ; Lombardo C; López-Ben S; Mabrut JY; Niesen W; Pardo F; Perinel J; Popescu I; Roeyen G; Sauvanet A; Prasad R; Sturesson C; Lesurtel M; Kleeff J; Salvia R; Besselink MG;
Ann Surg Oncol; 2018 May; 25(5):1440-1447. PubMed ID: 29532342
[TBL] [Abstract][Full Text] [Related]
25. Novel Prognostic Implications of DUPAN-2 in the Era of Initial Systemic Therapy for Pancreatic Cancer.
Sunagawa Y; Yamada S; Sato Y; Morimoto D; Sonohara F; Takami H; Inokawa Y; Hayashi M; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Fujii T; Kodera Y
Ann Surg Oncol; 2020 Jun; 27(6):2081-2089. PubMed ID: 31673938
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis.
Barenboim A; Lahat G; Geva R; Nachmany I; Nakache R; Goykhman Y; Brazowski E; Rosen G; Isakov O; Wolf I; Klausner JM; Lubezky N
Eur J Surg Oncol; 2018 Oct; 44(10):1619-1623. PubMed ID: 30146251
[TBL] [Abstract][Full Text] [Related]
27. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer.
Wanebo HJ; Glicksman AS; Vezeridis MP; Clark J; Tibbetts L; Koness RJ; Levy A
Arch Surg; 2000 Jan; 135(1):81-7; discussion 88. PubMed ID: 10636353
[TBL] [Abstract][Full Text] [Related]
28. [Surgical therapy of locally advanced and primary inoperable pancreatic carcinoma after neoadjuvant preoperative radiochemotherapy].
Rau HG; Wichmann MW; Wilkowski R; Heinemann V; Sackmann M; Helmberger T; Dühmke E; Schildberg FW
Chirurg; 2002 Feb; 73(2):132-7. PubMed ID: 11974476
[TBL] [Abstract][Full Text] [Related]
29. Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
Cloyd JM; Crane CH; Koay EJ; Das P; Krishnan S; Prakash L; Snyder RA; Varadhachary GR; Wolff RA; Javle M; Shroff RT; Fogelman D; Overman M; Wang H; Maitra A; Lee JE; Fleming JB; Katz MH
Cancer; 2016 Sep; 122(17):2671-9. PubMed ID: 27243381
[TBL] [Abstract][Full Text] [Related]
30. Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes.
Martin RC; Scoggins CR; Egnatashvili V; Staley CA; McMasters KM; Kooby DA
Arch Surg; 2009 Feb; 144(2):154-9. PubMed ID: 19221327
[TBL] [Abstract][Full Text] [Related]
31. Robotic and open distal pancreatectomy with celiac axis resection for locally advanced pancreatic body tumors: a single institutional assessment of perioperative outcomes and survival.
Ocuin LM; Miller-Ocuin JL; Novak SM; Bartlett DL; Marsh JW; Tsung A; Lee KK; Hogg ME; Zeh HJ; Zureikat AH
HPB (Oxford); 2016 Oct; 18(10):835-842. PubMed ID: 27506992
[TBL] [Abstract][Full Text] [Related]
32. The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer.
Kinsella TJ; Seo Y; Willis J; Stellato TA; Siegel CT; Harpp D; Willson JK; Gibbons J; Sanabria JR; Hardacre JM; Schulak JP
Am J Clin Oncol; 2008 Oct; 31(5):446-53. PubMed ID: 18838880
[TBL] [Abstract][Full Text] [Related]
33. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
Papalezova KT; Tyler DS; Blazer DG; Clary BM; Czito BG; Hurwitz HI; Uronis HE; Pappas TN; Willett CG; White RR
J Surg Oncol; 2012 Jul; 106(1):111-8. PubMed ID: 22311829
[TBL] [Abstract][Full Text] [Related]
34. Perioperative CT angiography assessment of locally advanced distal pancreatic carcinoma to evaluate feasibility of the modified Appleby procedure.
Gupta AP; Kawamoto S; Javed AA; Weiss MJ; Wolfgang CL; He J; Fishman EK; Vadvala HV
Eur J Radiol; 2020 Oct; 131():109248. PubMed ID: 32919264
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the prognostic impact of pre- and post-operative CA19-9, SPan-1, and DUPAN-II levels in patients with pancreatic carcinoma.
Kondo N; Murakami Y; Uemura K; Nakagawa N; Takahashi S; Ohge H; Sueda T
Pancreatology; 2017; 17(1):95-102. PubMed ID: 27746094
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma.
Mellon EA; Hoffe SE; Springett GM; Frakes JM; Strom TJ; Hodul PJ; Malafa MP; Chuong MD; Shridhar R
Acta Oncol; 2015 Jul; 54(7):979-85. PubMed ID: 25734581
[TBL] [Abstract][Full Text] [Related]
37. Effect of postoperative major complications on prognosis after pancreatectomy for pancreatic cancer: a retrospective review.
Watanabe Y; Nishihara K; Matsumoto S; Okayama T; Abe Y; Nakano T
Surg Today; 2017 May; 47(5):555-567. PubMed ID: 27704248
[TBL] [Abstract][Full Text] [Related]
38. Value of lymph node positivity in treatment planning for early stage pancreatic cancer.
Tran Cao HS; Zhang Q; Sada YH; Silberfein EJ; Hsu C; Van Buren G; Chai C; Katz MHG; Fisher WE; Massarweh NN
Surgery; 2017 Sep; 162(3):557-567. PubMed ID: 28666686
[TBL] [Abstract][Full Text] [Related]
39. Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer.
Del Chiaro M; Rangelova E; Halimi A; Ateeb Z; Scandavini C; Valente R; Segersvärd R; Arnelo U; Verbeke CS
HPB (Oxford); 2019 Feb; 21(2):219-225. PubMed ID: 30093144
[TBL] [Abstract][Full Text] [Related]
40. Feasibility and safety of distal pancreatectomy with en bloc celiac axis resection (DP-CAR) combined with neoadjuvant therapy for borderline resectable and unresectable pancreatic body/tail cancer.
Yoshitomi H; Sakai N; Kagawa S; Takano S; Ueda A; Kato A; Furukawa K; Takayashiki T; Kuboki S; Miyzaki M; Ohtsuka M
Langenbecks Arch Surg; 2019 Jun; 404(4):451-458. PubMed ID: 30868241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
